Anti-Acanthamoeba synergistic effect of chlorhexidine and Garcinia mangostana extract or α-mangostin against Acanthamoeba triangularis trophozoite and cyst forms.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
13 04 2021
13 04 2021
Historique:
received:
05
12
2020
accepted:
25
03
2021
entrez:
14
4
2021
pubmed:
15
4
2021
medline:
5
11
2021
Statut:
epublish
Résumé
Acanthamoeba spp. can cause amoebic keratitis (AK). Chlorhexidine is effective for AK treatment as monotherapy, but with a relative failure on drug bioavailability in the deep corneal stroma. The combination of chlorhexidine and propamidine isethionate is recommended in the current AK treatment. However, the effectiveness of treatment depends on the parasite and virulence strains. This study aims to determine the potential of Garcinia mangostana pericarp extract and α-mangostin against Acanthamoeba triangularis, as well as the combination with chlorhexidine in the treatment of Acanthamoeba infection. The minimal inhibitory concentrations (MICs) of the extract and α-mangostin were assessed in trophozoites with 0.25 and 0.5 mg/mL, for cysts with 4 and 1 mg/mL, respectively. The MIC of the extract and α-mangostin inhibited the growth of A. triangularis trophozoites and cysts for up to 72 h. The extract and α-mangostin combined with chlorhexidine demonstrated good synergism, resulting in a reduction of 1/4-1/16 of the MIC. The SEM results showed that Acanthamoeba cells treated with a single drug and its combination caused damage to the cell membrane and irregular cell shapes. A good combination displayed by the extract or α-mangostin and chlorhexidine, described for the first time. Therefore, this approach is promising as an alternative method for the management of Acanthamoeba infection in the future.
Identifiants
pubmed: 33850179
doi: 10.1038/s41598-021-87381-x
pii: 10.1038/s41598-021-87381-x
pmc: PMC8044166
doi:
Substances chimiques
Plant Extracts
0
Chlorhexidine
R4KO0DY52L
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
8053Références
Clin Microbiol Rev. 2003 Apr;16(2):273-307
pubmed: 12692099
Antioxid Redox Signal. 2014 Aug 10;21(5):682-99
pubmed: 24295217
Pathogens. 2020 May 22;9(5):
pubmed: 32456110
J Oral Sci. 2009 Sep;51(3):401-6
pubmed: 19776506
Phytother Res. 2015 Aug;29(8):1195-201
pubmed: 25943035
Nutrients. 2013 Aug 13;5(8):3163-83
pubmed: 23945675
Pathog Glob Health. 2020 May 18;114(4):194-204
pubmed: 32315247
Exp Parasitol. 2017 Dec;183:117-123
pubmed: 28778743
J Nat Prod. 2003 Aug;66(8):1124-7
pubmed: 12932141
Chem Pharm Bull (Tokyo). 2006 Jan;54(1):111-3
pubmed: 16394561
BMC Complement Altern Med. 2012 Jul 20;12:104
pubmed: 22818000
Parasitol Res. 2020 Jun;119(6):1943-1954
pubmed: 32385711
Korean J Parasitol. 2008 Sep;46(3):157-64
pubmed: 18830055
J Parasit Dis. 2020 Jun;44(2):491-495
pubmed: 32508430
Parasitol Res. 1998 Sep;84(9):746-52
pubmed: 9766904
Acta Parasitol. 2017 Dec 20;62(4):790-795
pubmed: 29035854
Parasite. 2015;22:10
pubmed: 25687209
Pharmacogn Rev. 2017 Jul-Sep;11(22):57-72
pubmed: 28989242
BMC Complement Altern Med. 2016 May 21;16:135
pubmed: 27208974
Curr Med Chem. 2005;12(21):2539-49
pubmed: 16250876
Food Chem Toxicol. 2011 Sep;49(9):2385-91
pubmed: 21723363
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6441-6450
pubmed: 27600042
J Clin Microbiol. 2008 Jan;46(1):338-40
pubmed: 18003807
Biol Direct. 2016 Dec 28;11(1):69
pubmed: 28031045
Planta Med. 2006 Aug;72(10):912-6
pubmed: 16902859
Parasitol Int. 2020 Feb;74:102002
pubmed: 31669294
Int J Parasitol Drugs Drug Resist. 2020 Aug;13:59-72
pubmed: 32512260
Korean J Parasitol. 2019 Aug;57(4):341-357
pubmed: 31533401
J Agric Food Chem. 2014 May 7;62(18):4127-34
pubmed: 24738849
Phytomedicine. 2005 Mar;12(3):203-8
pubmed: 15830842
Food Chem Toxicol. 2008 Feb;46(2):688-93
pubmed: 18029076